keyword
https://read.qxmd.com/read/38507297/prevalence-of-ocular-toxoplasmosis-among-people-living-with-hiv-a-systematic-review-and-meta-analysis
#21
REVIEW
Maria Kantzanou, Evangelos Kostares, Georgia Kostare, Fotini Boufidou, Antzela Tzanai, Michael Kostares, Athanasios Tsakris
Aim: To determine the prevalence of ocular toxoplasmosis among people living with HIV through a systematic review and meta-analysis. Materials & methods: A literature search was conducted, estimating pooled prevalence and performing quality assessment, outlier, influential and meta-regression analyses. Results: Twenty-nine studies were included in the analysis, revealing that the rate of ocular toxoplasmosis among people living with HIV was 0.37% (95% CI: 0.2-0.6). Substantial heterogeneity was observed among the studies...
March 20, 2024: Future Microbiology
https://read.qxmd.com/read/38504919/the-role-of-age-in-ocular-toxoplasmosis-clinical-signs-of-immunosenescence-and-inflammaging
#22
JOURNAL ARTICLE
Armin Taghavi Eraghi, Justus G Garweg, Uwe Pleyer
PURPOSE: This study aimed to investigate the association between age, immune response, and clinical presentation of ocular toxoplasmosis (OT). DESIGN: This was a monocentric, retrospective, observational cohort study. METHODS: A review of the medical records of patients with active OT at the Uveitis Center, Charité Universitätsmedizin, was conducted. Baseline parameters included age at presentation, visual acuity, intraocular pressure (IOP), size and location of active lesions, inflammatory activity, antibody index (AI), and complications of intraocular inflammation...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38502506/monitoring-of-lipid-fluxes-between-host-and-plastid-bearing-apicomplexan-parasites
#23
JOURNAL ARTICLE
Sarah Charital, Amandine Lourdel, Nyamekye Quansah, Cyrille Y Botté, Yoshiki Yamaryo-Botté
Apicomplexan parasites are unicellular eukaryotes responsible for major human diseases such as malaria and toxoplasmosis, which cause massive social and economic burden. Toxoplasmosis, caused by Toxoplasma gondii, is a global chronic infectious disease affecting ~1/3 of the world population and is a major threat for any immunocompromised patient. To date, there is no efficient vaccine against these parasites and existing treatments are threatened by rapid emergence of parasite resistance. Throughout their life cycle, Apicomplexa require large amount of nutrients, especially lipids for propagation and survival...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38502497/complex-endosymbiosis-ii-the-nonphotosynthetic-plastid-of-apicomplexa-parasites-the-apicoplast-and-its-integrated-metabolism
#24
JOURNAL ARTICLE
Nyamekye Quansah, Charital Sarah, Yoshiki Yamaryo-Botté, Cyrille Y Botté
Chloroplasts are essential organelles that are responsible for photosynthesis in a wide range of organisms that have colonized all biotopes on Earth such as plants and unicellular algae. Interestingly, a secondary endosymbiotic event of a red algal ancestor gave rise to a group of organisms that have adopted an obligate parasitic lifestyle named Apicomplexa parasites. Apicomplexa parasites are some of the most widespread and poorly controlled pathogens in the world. These infectious agents are responsible for major human diseases such as toxoplasmosis, caused by Toxoplasma gondii, and malaria, caused by Plasmodium spp...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38501871/the-acyl-coa-synthetase-tg-acs1-allows-neutral-lipid-metabolism-and-extracellular-motility-in-toxoplasma-gondii-through-relocation-via-its-peroxisomal-targeting-sequence-pts-under-low-nutrient-conditions
#25
JOURNAL ARTICLE
Sarah Charital, Serena Shunmugam, Sheena Dass, Anna Maria Alazzi, Christophe-Sébastien Arnold, Nicholas J Katris, Samuel Duley, Nyamekye A Quansah, Fabien Pierrel, Jérôme Govin, Yoshiki Yamaryo-Botté, Cyrille Y Botté
Apicomplexa parasites cause major diseases such as toxoplasmosis and malaria that have major health and economic burdens. These unicellular pathogens are obligate intracellular parasites that heavily depend on lipid metabolism for the survival within their hosts. Their lipid synthesis relies on an essential combination of fatty acids (FAs) obtained from both de novo synthesis and scavenging from the host. The constant flux of scavenged FA needs to be channeled toward parasite lipid storage, and these FA storages are timely mobilized during parasite division...
March 19, 2024: MBio
https://read.qxmd.com/read/38496314/ameliorative-effects-of-propolis-and-wheat-germ-oil-on-acute-toxoplasmosis-in-experimentally-infected-mice-are-associated-with-reduction-in-parasite-burden-and-restoration-of-histopathological-changes-in-the-brain-uterus-and-kidney
#26
JOURNAL ARTICLE
Ehab Kotb Elmahallawy, Fatma Abo Zakaib Ali, Enrique Raya-Álvarez, Alaa Fehaid, Khaled A Abd El-Razik, Hassan Ali Mohamed El Fadaly, Manal F El-Khadragy, Amal S M Sayed, Ashraf H Soror, Alaa S Alhegaili, Amira A Saleh, Abdulsalam A M Alkhaldi, Abd El-Nasser A Madboli, Ahmad Agil, Ashraf Mohamed Barakat
Toxoplasmosis continues to be a prevalent parasitic zoonosis with a global distribution. This disease is caused by an intracellular parasite known as Toxoplasma gondii , and the development of effective novel drug targets to combat it is imperative. There is limited information available on the potential advantages of wheat germ oil (WGO) and propolis, both individually and in combination, against the acute phase of toxoplasmosis. In this study, acute toxoplasmosis was induced in Swiss albino mice, followed by the treatment of infected animals with WGO and propolis, either separately or in combination...
2024: Frontiers in Veterinary Science
https://read.qxmd.com/read/38474432/in-vitro-anti-toxoplasma-activity-of-extracts-obtained-from-tabebuia-rosea-and-tabebuia-chrysantha-the-role-of-%C3%AE-amyrin
#27
JOURNAL ARTICLE
Maria Camila Cardona-Trujillo, Francisco Javier Jiménez-González, Luz Angela Veloza, Juan Carlos Sepúlveda-Arias
Toxoplasmosis is a parasitic disease caused by the protozoan Toxoplasma gondii that is highly prevalent worldwide. Although the infection is asymptomatic in immunocompetent individuals, it severely affects immunocompromised individuals, causing conditions such as encephalitis, myocarditis, or pneumonitis. The limited therapeutic efficacy of drugs currently used to treat toxoplasmosis has prompted the search for new therapeutic alternatives. The aim of this study was to determine the anti- Toxoplasma activity of extracts obtained from two species of the genus Tabebuia ...
February 20, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38470023/multicenter-evaluation-of-the-toxoplasma-gondii-real-tm-sacace-kit-performance-for-the-molecular-diagnosis-of-toxoplasmosis
#28
JOURNAL ARTICLE
Juliette Guitard, Marie-Pierre Brenier-Pinchart, Emmanuelle Varlet-Marie, Frédéric Dalle, Celia Rouges, Nicolas Argy, Julie Bonhomme, Agathe Capitaine, Hélène Guégan, Rose-Anne Lavergne, Marie-Laure Dardé, Hervé Pelloux, Florence Robert-Gangneux, Hélène Yera, Yvon Sterkers
The molecular detection of Toxoplasma gondii DNA is a key tool for the diagnosis of disseminated and congenital toxoplasmosis. This multicentric study from the Molecular Biology Pole of the French National Reference Center for toxoplasmosis aimed to evaluate Toxoplasma gondii Real-TM PCR kit (Sacace). The study compared the analytical and clinical performances of this PCR assay with the reference PCRs used in proficient laboratories. PCR efficiencies varied from 90% to 112%; linearity zone extended over four log units (R2 > 0...
March 12, 2024: Journal of Clinical Microbiology
https://read.qxmd.com/read/38464220/bicyclic-pyrrolidine-inhibitors-of-toxoplasma-gondii-phenylalanine-t-rna-synthetase-with-antiparasitic-potency-in-vitro-and-brain-exposure
#29
Chloe C Ence, Taher Uddin, Julien Borrel, Payal Mittal, Han Xie, Jochen Zoller, Amit Sharma, Eamon Comer, Stuart L Schreiber, Bruno Melillo, L David Sibley, Arnab K Chatterjee
UNLABELLED: Previous studies have shown that bicyclic azetidines are potent and selective inhibitors of apicomplexan phenylalanine tRNA synthetase (PheRS), leading to parasite growth inhibition in vitro and in vivo , including in models of Toxoplasma infection. Despite these useful properties, additional optimization is required for the development of efficacious treatments of toxoplasmosis from this inhibitor series, in particular to achieve sufficient exposure in the brain. Here, we describe a series of PheRS inhibitors built on a new bicyclic pyrrolidine core scaffold designed to retain the exit-vector geometry of the isomeric bicyclic azetidine core scaffold while offering avenues to sample diverse chemical space...
February 28, 2024: bioRxiv
https://read.qxmd.com/read/38464000/constitutive-upregulation-of-transcription-factors-underlies-permissive-bradyzoite-differentiation-in-a-natural-isolate-of-toxoplasma-gondii
#30
Jing Xia, Yong Fu, Wanyi Huang, L David Sibley
UNLABELLED: Toxoplasma gondii bradyzoites play a critical role in pathology due to their long-term persistence in intermediate hosts and their potential to reactivate, resulting in severe diseases in immunocompromised individuals. Currently there is no effective treatment for eliminating bradyzoites. Hence, better in vitro models of T. gondii cyst development would facilitate identification of therapeutic targets for bradyzoites. Herein we characterized a natural isolate of T. gondii , called Tg68, which showed slower in vitro replication of tachyzoites, and permissive bradyzoite development under stress conditions in vitro ...
February 28, 2024: bioRxiv
https://read.qxmd.com/read/38462298/seroprevalence-of-toxoplasma-gondii-and-neospora-caninum-in-family-farming-goats-from-the-luracatao-valley-salta-argentina
#31
JOURNAL ARTICLE
Carina Basset, María Laura Gos, Kevin D Steffen, Elisa Helman, Bruno Fitte, Paula L Olaizola, Juan Manuel Unzaga
Toxoplasma gondii and Neospora caninum infections are important causes of abortion in ruminants. The objective of this study was to determine the seroprevalence and frequency of T. gondii and N. caninum titers in goats raised by family farmers in the Luracatao Valley of Salta province, Argentina. A total of 259 serum samples were collected from adult goats in 42 family farms in nine communities and tested for indirect fluorescent antibody test (IFAT, cut-off 1:100). Seroprevalences were 34.36% (89/259) for T...
April 2024: Veterinary Parasitology (Amsterdam)
https://read.qxmd.com/read/38449361/congenital-toxoplasmosis-and-long-term-outcomes
#32
JOURNAL ARTICLE
Ozlem Ozgur Gundeslioglu, Zeliha Haytoglu, Ebru Esen, Derya Alabaz, Ummuhan Cay, Ferda Ozlu, Filiz Kibar, Salih Cetiner
OBJECTIVE: Congenital toxoplasmosis (CT) can have severe early and late sequelae in children. In this study, we aimed to evaluate the demographic, clinical, treatment characteristics of patients diagnosed with congenital Toxoplasma infection and to highlight the long-term complications of the patients. METHODS: Patients with CT were included in this study who were followed between 2010 and 2022 in Cukurova University Medical Faculty Hospital. Demographic, clinical and treatment characteristics were searched retrospectively...
March 5, 2024: Türkiye Parazitolojii Dergisi
https://read.qxmd.com/read/38448975/lipid-metabolism-the-potential-targets-for-toxoplasmosis-treatment
#33
REVIEW
Tian-Yi He, Ye-Tian Li, Zhen-Di Liu, Hao Cheng, Yi-Feng Bao, Ji-Li Zhang
Toxoplasmosis is a zoonosis caused by Toxoplasma gondii (T. gondii). The current treatment for toxoplasmosis remains constrained due to the absence of pharmaceutical interventions. Thus, the pursuit of more efficient targets is of great importance. Lipid metabolism in T. gondii, including fatty acid metabolism, phospholipid metabolism, and neutral lipid metabolism, assumes a crucial function in T. gondii because those pathways are largely involved in the formation of the membranous structure and cellular processes such as division, invasion, egress, replication, and apoptosis...
March 6, 2024: Parasites & Vectors
https://read.qxmd.com/read/38441016/seroepidemiology-of-toxoplasma-gondii-infection-in-patients-with-liver-disease-in-southeastern-iran
#34
JOURNAL ARTICLE
Atefeh Oveisipour, Maryam Hataminejad, Bahman Fouladi, Hakim Azizi
INTRODUCTION: Recent research has been concentrated on investigating the involvement of Toxoplasma gondii (T. gondii) in the progression of liver disorders. This study aims to investigate the prevalence of T. gondii infection in patients with non-alcoholic fatty liver disease (NAFLD), as well as the effects of toxoplasmosis infection on biological biomarkers such as aspirate transaminase (AST), alanine transaminase (ALT), cholesterol (Chol), and triglyceride (Tg) levels in Sistan, southeast Iran...
March 4, 2024: Recent Adv Antiinfect Drug Discov
https://read.qxmd.com/read/38440758/modulation-of-cxcl10-activity-as-a-therapeutic-target-of-ocular-toxoplasmosis-in-diabetic-mice
#35
JOURNAL ARTICLE
Mennat-Elrahman Ahmed Fahmy, Amany Ahmed Abdel-Aal, Maisa Ahmed Shalaby, Ragaa Issa, Manal Badawi, Marwa A Fouly
Ocular toxoplasmosis is likely the most common cause of infectious posterior uveitis worldwide. CXCL10 chemokine has an important role in the maintenance of the T-cell response and the control of Toxoplasma gondii in the eye during chronic infection. Drugs that can modulate the chemokine activity could be effective against the parasite. In this work, CXCL10 local retinal expression was investigated in a diabetic mouse model with ocular toxoplasmosis for the first time. In addition, the efficacy of naphthoquinones and quinolones was compared to spiramycin (SP) in treating the infection and modulating the chemokine expression...
March 2024: Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology
https://read.qxmd.com/read/38438515/toxoplasma-gondii-infection-associated-with-inflammasome-activation-and-neuronal-injury
#36
JOURNAL ARTICLE
Dimitrios Andreou, Nils Eiel Steen, Lynn Mørch-Johnsen, Kjetil Nordbø Jørgensen, Laura A Wortinger, Claudia Barth, Attila Szabo, Kevin S O'Connell, Tove Lekva, Gabriela Hjell, Ingrid Torp Johansen, Monica B E G Ormerod, Unn K Haukvik, Pål Aukrust, Srdjan Djurovic, Robert H Yolken, Ole A Andreassen, Thor Ueland, Ingrid Agartz
Toxoplasma gondii (TOXO) infection typically results in chronic latency due to its ability to form cysts in the brain and other organs. Latent toxoplasmosis could promote innate immune responses and impact brain function. A large body of evidence has linked TOXO infection to severe mental illness (SMI). We hypothesized that TOXO immunoglobulin G (IgG) seropositivity, reflecting previous infection and current latency, is associated with increased circulating neuron-specific enolase (NSE), a marker of brain damage, and interleukin-18 (IL-18), an innate immune marker, mainly in SMI...
March 4, 2024: Scientific Reports
https://read.qxmd.com/read/38435971/-toxoplasma-gondii-infection-in-people-with-schizophrenia-is-related-to-higher-hair-glucocorticoid-levels
#37
JOURNAL ARTICLE
Emy Beaumont, Jacques Brodeur, Frédéric Thomas, Antoine M Dujon, Sonia J Lupien
INTRODUCTION: Toxoplasma gondii (TG) is a common protozoan parasite infecting approximately one third of the human population. Animal studies have shown that this parasite can manipulate its host behavior. Based on this, human studies have assessed if TG can be involved in mental health disorders associated with important behavioral modifications such as schizophrenia. However, results have been discrepant. Given that TG has a strong impact on fear and risk-taking processes in animal studies and that fear and risk-taking behaviors are associated with the human stress response, we tested whether glucocorticoid biomarkers (salivary and hair) differ in people with schizophrenia and controls as a function of TG status...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38431113/potent-hydroxamate-derived-compounds-arrest-endodyogeny-of-toxoplasma-gondii-tachyzoites
#38
JOURNAL ARTICLE
Carlla Assis Araujo-Silva, Katharina Vögerl, Ferdinand Breu, Manfred Jung, Andreia Luiza Oliveira Costa, Wanderley De Souza, Franz Bracher, Erica S Martins-Duarte, Rossiane C Vommaro
Toxoplasmosis is a zoonosis that is a worldwide health problem, commonly affecting fetal development and immunodeficient patients. Treatment is carried out with a combination of pyrimethamine and sulfadiazine, which can cause cytopenia and intolerance and does not lead to a parasitological cure of the infection. Lysine deacetylases (KDACs), which remove an acetyl group from lysine residues in histone and non-histone proteins are found in the Toxoplasma gondii genome. Previous work showed the hydroxamate-type KDAC inhibitors Tubastatin A (TST) and Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) were effective against T...
February 29, 2024: Experimental Parasitology
https://read.qxmd.com/read/38429153/protective-efficacy-of-recombinant-toxoplasma-gondii-dense-granule-protein-15-against-toxoplasmosis-in-c57bl-6-mice
#39
JOURNAL ARTICLE
Tanjila Hasan, Naomi Shimoda, Shu Nakamura, Barbara A Fox, David J Bzik, Nanako Ushio-Watanabe, Yoshifumi Nishikawa
Toxoplasma gondii is a pervasive protozoan parasite that is responsible for significant zoonoses. A wide array of vaccines using different effector molecules of T. gondii have been studied worldwide to control toxoplasmosis. None of the existing vaccines are sufficiently effective to confer protective immunity. Among the different Toxoplasma-derived effector molecules, T. gondii dense granule protein 15 from the type II strain (GRA15 (II)) was recently characterized as an immunomodulatory molecule that induced host immunity via NF-κB...
February 29, 2024: Vaccine
https://read.qxmd.com/read/38424737/-toxoplasma-gondii-aspartic-protease-5-structural-basis-of-substrate-binding-and-inhibition-mechanism
#40
JOURNAL ARTICLE
Satadru Chakraborty, Anuradha Deshmukh, Pooja Kesari, Prasenjit Bhaumik
Toxoplasma gondii , a worldwide prevalent parasite is responsible for causing toxoplasmosis in almost all warm-blooded animals, including humans. Golgi-resident T. gondii aspartic protease 5 ( Tg ASP5) plays an essential role in the maturation and export of the effector proteins those modulate the host immune system to establish a successful infection. Hence, inhibiting this enzyme can be a possible therapeutic strategy against toxoplasmosis. This is the first report of the detailed structural investigations of the Tg ASP5 mature enzyme using molecular modeling and an all-atom simulation approach which provide in-depth knowledge of the active site architecture of Tg ASP5...
February 29, 2024: Journal of Biomolecular Structure & Dynamics
keyword
keyword
42533
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.